Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tada

Showing results (511-520 of 734) with videos related to

Pageof 74
Sort By:
Toxicology Letters|February 18, 1999
Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesisT Shirai, S Takahashi, L Cui, et al.
Chemical & Pharmaceutical Bulletin|March 8, 2000
Development of plasmin-selective inhibitors and studies of their structure-activity relationshipY Okada, Y Matsumoto, Y Tsuda, et al.
International Journal of Cardiology|January 1, 1996
Direct cardiotoxic effects of cocaine and cocaethylene on isolated cardiomyocytesH Bai, K Otsu, M N Islam, et al.
Journal of Neuroimmunology|March 1, 1994
Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivoM Tada, A C Diserens, I Desbaillets, et al.
Chemical & Pharmaceutical Bulletin|September 9, 1999
Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backboneA Fukumizu, Y Tsuda, K Wanaka, et al.
Biopolymers|June 25, 1999
Development of plasma kallikrein selective inhibitorsY Okada, Y Tsuda, M Tada, et al.
Development (Cambridge, England)|September 8, 1999
Bix4 is activated directly by VegT and mediates endoderm formation in Xenopus developmentE S Casey, M Tada, L Fairclough, et al.
Chemical & Pharmaceutical Bulletin|January 6, 2001
Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationshipY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|November 29, 2001
Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitorsY Tsuda, M Tada, K Wanaka, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infectionT Kanamaru, Y Nakano, Y Toyoda, et al.
Pageof 74

Showing results (511-520 of 734) with videos related to

Sort By:
Pageof 74
Toxicology Letters|February 18, 1999
Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesisT Shirai, S Takahashi, L Cui, et al.
Chemical & Pharmaceutical Bulletin|March 8, 2000
Development of plasmin-selective inhibitors and studies of their structure-activity relationshipY Okada, Y Matsumoto, Y Tsuda, et al.
International Journal of Cardiology|January 1, 1996
Direct cardiotoxic effects of cocaine and cocaethylene on isolated cardiomyocytesH Bai, K Otsu, M N Islam, et al.
Journal of Neuroimmunology|March 1, 1994
Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivoM Tada, A C Diserens, I Desbaillets, et al.
Chemical & Pharmaceutical Bulletin|September 9, 1999
Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backboneA Fukumizu, Y Tsuda, K Wanaka, et al.
Biopolymers|June 25, 1999
Development of plasma kallikrein selective inhibitorsY Okada, Y Tsuda, M Tada, et al.
Development (Cambridge, England)|September 8, 1999
Bix4 is activated directly by VegT and mediates endoderm formation in Xenopus developmentE S Casey, M Tada, L Fairclough, et al.
Chemical & Pharmaceutical Bulletin|January 6, 2001
Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationshipY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|November 29, 2001
Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitorsY Tsuda, M Tada, K Wanaka, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infectionT Kanamaru, Y Nakano, Y Toyoda, et al.
Pageof 74